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Clinico-pathological discrepancies are more frequent in settings in which limited diagnostic
techniques are available, but there is little information on their actual impact.
Aim
We assessed the accuracy of the clinical diagnoses in a tertiary referral hospital in sub-
Saharan Africa by comparison with post-mortem findings. We also identified potential risk
factors for misdiagnoses.
Methods
One hundred and twelve complete autopsy procedures were performed at the Maputo Cen-
tral Hospital (Mozambique), from November 2013 to March 2015. We reviewed the clinical
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Editor: José Moreira, Fundacao Oswaldo Cruz,
BRAZIL
Received: April 9, 2019
Accepted: July 20, 2019
Published: September 6, 2019
Copyright: © 2019 Ordi et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files. Any additional data use and
transfer is monitored by ISGlobal’s Data
Management and Biostatistics Unit, who can be
contacted by email at ubioesdm@isglobal.org.
Funding: The CaDMIA research project (Validation
of the minimally invasive autopsy tool for cause of
death investigation in developing countries) was
funded by the Bill & Melinda Gates Foundation
records. Major clinico-pathological discrepancies were assessed using a modified version
of the Goldman and Battle classification.
Results
Major diagnostic discrepancies were detected in 65/112 cases (58%) and were particularly
frequent in infection-related deaths (56/80 [70%] major discrepancies). The sensitivity of the
clinical diagnosis for toxoplasmosis was 0% (95% CI: 0–37), 18% (95% CI: 2–52) for inva-
sive fungal infections, 25% (95% CI: 5–57) for bacterial sepsis, 34% (95% CI: 16–57), for
tuberculosis, and 46% (95% CI: 19–75) for bacterial pneumonia. Major discrepancies were
more frequent in HIV-positive than in HIV-negative patients (48/73 [66%] vs. 17/39 [44%];
p = 0.0236).
Conclusions
Major clinico-pathological discrepancies are still frequent in resource constrained settings.
Increasing the level of suspicion for infectious diseases and expanding the availability of
diagnostic tests could significantly improve the recognition of common life-threatening infec-
tions, and thereby reduce the mortality associated with these diseases. The high frequency
of clinico-pathological discrepancies questions the validity of mortality reports based on clini-
cal data or verbal autopsy.
Introduction
Healthcare systems worldwide face the challenge of improving the quality of care they deliver
in order to improve health outcomes. Complete autopsy is the gold standard methodology for
cause of death investigation and is the most informative tool for retrospective quality assess-
ment of clinical diagnoses [1,2]. Previous studies comparing clinical diagnoses and autopsy
findings revealed major discrepancies in approximately 10–40% of the deceased patients
undergoing post-mortem examination [3–5]. Thus, complete diagnostic autopsy is an impor-
tant tool for quality control of clinical practice [6,7].
However, autopsy rates have been declining over the past decades [3–5,8,9]. The reasons
for this decline have been discussed previously in literature [3,4,6] and include, among others,
introduction of modern diagnostic tools in clinical practice. However, it is widely accepted
that clinico-pathological discrepancies still occur even in the era of high-tech medicine
[7,8,10], being much more frequent in low and middle income countries (LMIC), in which the
availability of diagnostic techniques is limited [9]. Therefore, autopsies still have a crucial role
in quality control of the clinical diagnosis and overall patient management. Learning from
individual and system-related diagnostic errors can contribute to improving the quality of care
[4].
In this study, we assessed the concordance between clinical and autopsy diagnoses by deter-
mining the major and minor discrepancy rates in a total of 112 consecutive autopsies per-
formed in adults, excluding maternal deaths, conducted at the Maputo Central Hospital
(MCH) in Mozambique. We analysed the influence of several factors on the frequency of
major discrepancies, including diagnostic category, HIV infection and length of time from
admission to death. We also evaluated the association between clinical signs and symptoms
and frequency of errors. These results could contribute to identifying future patients at a
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higher risk of misdiagnosis and may help to define strategies to implement diagnostic tests to
confirm or exclude frequent diseases causing death.
Material and methods
Study area and design
This was an observational study performed from November 2013 to March 2015 at the Depart-
ment of Pathology in collaboration with the Department of Internal Medicine of the Maputo
Central Hospital, a 1500-bed public tertiary health care centre in Maputo city, the capital of
Mozambique. The study was part of the validation of minimally invasive autopsy (MIA)
against the gold standard complete autopsy [11–14]. The inclusion criteria were: 1) a complete
autopsy requested by the clinician as part of the medical evaluation of the patient; 2) verbal
informed consent to perform the autopsy given by the relatives; and 3) age older than 15 years.
Traumatic and maternal deaths were excluded from this analysis. From November 2013 to
March 2015, two autopsies were prospectively included per day. In order to select these two
cases per day among the daily autopsy requests received at the department (between 5 and 12
per day) without introducing selection biases, the two patients with death recorded closest to
before the time of 8.00 a.m. were included in the study.
Autopsy procedures and laboratory analyses
A detailed description of the pathological and microbiological methodology of the complete
autopsies has been reported previously [11–14]. Briefly, a dissection was performed with mac-
roscopic evaluation of all the organs following a standardized macroscopic protocol [15]. Sam-
ples of blood, cerebrospinal fluid (CSF), liver, lungs, bone marrow, central nervous system
(CNS), heart, kidney, spleen and any grossly identified lesion were obtained. Samples were
obtained from all the organs for microbiological and histological analyses.
Macroscopic and microscopic autopsy data were evaluated by a team of two pathologists.
For histologic examination, all samples were routinely stained with haematoxylin and eosin.
Complementary histochemical and/or immunohistochemical stains were also performed if
required for the diagnosis. Two microbiologists analysed the microbiological results according
to methodology described elsewhere [13]. Briefly, universal screening was performed in all the
cases, including the detection of Plasmodium falciparum by PCR, detection of antibodies
against human immunodeficiency virus (HIV)-1/2, as well as cultures for bacteria and fungi
using blood and CSF samples. Determination of viral load was also performed in samples
tested positive for antibodies against HIV. Additional microbiological screening tests were
included in all HIV-positive cases, including real time PCR in CSF, CNS and lung for Toxo-
plasma gondii, Mycobacterium tuberculosis and Cryptococcus spp. and in lung samples for
Pneumocystis jirovecii. Other microorganisms were also tested according to the pathological
findings observed in the tissues obtained during the MIA procedure.
Determination of the cause of death
A team composed of a pathologist, a microbiologist, and a clinician with expertise in infectious
diseases and epidemiology evaluated all the data of the autopsy (macroscopic findings, histo-
logical reports and microbiological results) in combination with clinical data, and assigned the
final diagnosis of cause of death (gold standard).
All morbid conditions directly leading to death, underlying conditions (if present), and any
other conditions that could contribute to death were codified according to the International
Classification of Diseases, Tenth Revision (ICD-10). Diagnoses were categorised into the
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following diagnostic groups: tuberculosis, invasive fungal infections, toxoplasmosis, bacterial
sepsis, disseminated viral infections, bacterial pneumonias, viral pneumonias, pericarditis,
bacterial meningitis, viral meningoencephalitis, gastrointestinal infections, malignant tumours
and other non-infectious diseases (cardiovascular, kidney, gastrointestinal and pulmonary dis-
eases). The main final diagnosis was used to define the disease category.
Review of the clinical charts
Clinical information from all the patients recruited was retrospectively abstracted using a stan-
dardised questionnaire (S1 Form). The same investigator (Q.B.) performed the clinical data
abstraction of all cases after thorough revision of the entire medical record. The data collection
included, among others, retrieving demographic data, past medical history, as well as informa-
tion about the inpatient admission process and the clinical information of the disease during
hospitalisation, including signs and symptoms, physical examination, laboratory results, imag-
ing results and treatment received. Up to five clinical diagnoses registered in the medical
record were selected. We assumed that first diagnosis listed in the clinical record was the prin-
cipal diagnosis, and the remaining diagnoses were classified as secondary. All treatments
received by the patients during admission were also evaluated.
Assessment of discrepancies between clinical and autopsy diagnoses
Clinico-pathological discrepancies were classified according to the criteria of Goldman modi-
fied by Battle, and as non-classifiable cases [16–18]. Major discrepancies were directly related
to death and were grouped as class I or class II errors. As described previously [19], class I
error had a direct impact on the survival of the patient t (e.g., pulmonary infarction treated
as pneumonia), while class II error, if recognized, would not have altered the survival of the
patient (e.g., missed pneumonia in a patient with disseminated malignant neoplasm). Class III
(non-diagnosed diseases that would have eventually affected the prognosis) and class IV dis-
crepancies involved minor diagnoses, unrelated to cause of death [19]. Concordant diagnoses
were classified as class V and non-classifiable cases were included in class VI (e.g., autopsy
with no-conclusive diagnosis).
Each case was assessed blindly by two investigators (C.Mo., A.L.G.B.) and the two inter-
pretations were compared. Discrepant cases were evaluated by a third rater (C.Me.). Each
rater was provided with an excel file containing the following information: a) autopsy final
diagnosis, antecedent causes, and other significant conditions; b) clinical diagnoses extracted
from the medical record including up to five diagnoses. Assessment of the clinical errors was
made unidirectionally, that is, looking at whether the autopsy diagnosis was identified among
the clinical diagnoses, regardless of whether there were other clinical diagnoses not confirmed
by the autopsy. A case was classified as a major discrepancy only when there was no coinci-
dence between any of the five clinical diagnoses listed by the clinicians and the final cause of
death identified at the autopsy. In each case, only the worst diagnostic error was considered.
The etiological agent was considered to assess a clinic-pathological discrepancy for specific
infectious diseases including tuberculosis, toxoplasmosis, and invasive fungal diseases. Once
the assessment of the clinic-pathological discrepancy had been completed, the treatments
received by the patients were evaluated in order to verify the coherence with the clinical
diagnoses.
Definitions and statistical methods
False-negative cases contained class I and II discrepancies in which the autopsy diagnosis was
in the assessed diagnostic category but the clinical diagnosis was in another category. False-
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positive diagnoses were cases with major discrepancies (class I and II), in which the clinical
diagnosis was in the assessed diagnostic category but not the autopsy diagnosis. The concor-
dance between raters was assessed by the Kappa statistic, which adjusts for chance agreement,
and interpreted as suggested by Landis and Koch [20]. Proportions were compared by chi-
square test, and logistic regression with penalised likelihood was used to evaluate factors asso-
ciated with major clinical errors [21,22].The sensitivity, specificity, positive (PPV) and negative
predictive values (NPV) for each diagnosis were calculated. Data were analysed with the
STATA program (Version 15, StataCorp 2017, College Station, TX, USA).
Results
The study included 112 autopsies performed in adults (57 males and 55 females, median age
37 years, range 15–76). Seventy-three out of the 112 patients (65%) tested positive for antibod-
ies against HIV in the blood obtained at complete autopsy. The final cause of death was attrib-
uted by the autopsy to infectious disease in 80/112 (71%) cases, followed by malignant
tumours in 16/112 (14%) and other non-infectious disease in 16/112 (14%) cases.
In 87 out of the 112 cases, the two raters attributed the same type of error (78% agreement).
The kappa value between the two evaluations was 0.6520 (95% CI 0�5423–0.7616, p<0.0001,
substantial agreement). A discordant evaluation was observed in 25 cases (22%), thus requiring
a third evaluation.
Overall, diagnostic discrepancy was observed in 71/112 (63%) of the cases. A major diag-
nostic discrepancy was detected in 65 (58%) deaths, 63 (56%) of which were classified as class
I, and two (2%) as class II. A minor diagnostic discrepancy (class III or IV) was identified in
six cases (5%) and included one class III, and five class IV errors. In 41 deaths (37%), there was
complete agreement between the clinical and the autopsy diagnoses (class V). No time trends
concerning the clinical-pathological discrepancies were identified throughout the years (25/45
[56%] of major errors in 2013 vs. 40/67 [60%] in 2014; p = 0.6629).
Table 1 shows the causes of death detected in the autopsy, the number of clinical diagnoses
for each cause of death suspected pre-mortem by the clinician, the number and percentage of
false negative (major diagnostic errors) and false positive diagnoses, as well as the sensitivity,
specificity, PPV, and NPV of the clinical diagnosis for each diagnostic category.
A major discrepancy was observed in 56/80 (70%) of the deaths of infectious origin. The
diagnosis of tuberculosis was not clinically suspected in 15/23 cases (65% major clinical dis-
crepancies). A major clinical error was observed in 9/16 (56%) of miliary tuberculosis, 4/5
(80%) of pulmonary tuberculosis and 2/2 (100%) of tuberculous meningitis.
A diagnosis of invasive fungal infection was clinically unsuspected in 9/11 cases (82% major
clinical discrepancies). A major clinical error was identified in 5/7 cryptococcosis, 2/2 pulmo-
nary pneumocystosis, 1/1 mucormycosis and 1/1 disseminated candida infection). None of the
eight cases of toxoplasmosis confirmed in the autopsy was clinically suspected (100% major
clinical discrepancies).
The diagnosis of bacterial sepsis was not clinically suspected in 9/12 cases (75% major clini-
cal discrepancies). Bacterial pneumonia was not clinically suspected in 7/13 cases (54% major
discrepancies). Bacterial infections of the CNS were not clinically suspected in 4/7 cases (57%
major clinical discrepancies).
The diagnosis of malignant tumour was missed in 5/16 cases (31% major discrepancies; 0/5
liver cell carcinoma, 0/3 carcinoma of the uterine cervix, 1/3 malignant lymphomas, 1/2 Kapo-
si’s sarcoma, 1/1 myeloid leukaemia, 1/1 brain tumour, 1/1 undifferentiated malignant tumour
of unknown primary).
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The diagnosis of other non-infectious disease was not suspected as a cause of death in 4/16
cases (25% major discrepancies; 1/11 cardiovascular disease, 2/3 renal and gastrointestinal dis-
eases and 1/2 pulmonary diseases).
“Eighty-six of the patients died at the internal medicine wards, 15 at the emergency room
and 11 at the intensive care unit. No differences were observed in percentage of major errors
between deceases occurring at the different units (49/86 [57%], 9/15 [60%] and 7/11 [64%],
respectively, p = 0.9465).”
S1 Table shows the age, the sex, the HIV status as reported in the clinical records, the clini-
cal diagnoses (up to five) registered in the clinical records, the autopsy diagnosis, the HIV sta-
tus at autopsy, and the final assessment of the clinico-pathological discrepancy of each
particular patient. Meningoencephalitis was the most common false positive diagnosis.
Although some of the diseases established as the autopsy diagnosis could cause meningoen-
cephalitic symptoms (e.g. tuberculosis, cryptococcosis, etc.), none of these patients had
received adequate treatment for the disease causing death.
HIV infection was clinically known in 62 out of the 73 patients (85%) in whom HIV anti-
bodies were identified in the autopsy, whereas HIV had not been documented in 11 patients.
Six of the 11 cases with no HIV test performed pre-mortem had died within 24 hours of admis-
sion. According to the clinical records, only 48/73 HIV-positive patients (66%) had received
antiretroviral therapy prior to admission. Table 2 shows the distribution of the clinico-patho-
logical discrepancies and the main cause of death according the HIV status. The percentage of
major errors in HIV-positive patients was higher than in HIV-negative patients.
Information on the latest CD4 T-cell counts was available in 21/73 HIV positive subjects.
No differences in percentage of major errors were observed between patients with<200 and
>200 CD4 cells/mm3 (6/8, 75% vs. 12/13, 93%; p = 0.5308). No differences were observed
Table 1. Causes of death determined by the autopsy and the clinical diagnosis, absolute numbers and percentages of false negative and false positive clinical diagno-
ses and sensitivity, specificity, PPV, and NPV of the clinical diagnosis for each diagnostic category.












n n n % n % % 95%CI % 95%CI % 95%CI % 95%CI
Tuberculosis 23 19 15 65 11 12 34 16–57 88 79–94 42 20–66 84 75–91
Invasive fungal infections 11 7 9 82 5 5 18 2–52 95 89–98 29 4–71 91 84–96
Toxoplasmosis 8 2 8 100 2 2 0 0–37 98 93–100 0 0–84 93 86–97
Bacterial sepsis 12 5 9 75 2 2 25 5–57 98 93–100 60 15–95 92 85–96
Disseminated herpesvirus 1 1 0 0 0 0 100 2–100 100 97–100 100 2–100 100 97–100
Bacterial pneumonia 13 21 7 54 15 15 46 19–75 85 76–91 29 11–52 92 85–97
Viral pneumonia 2 0 2 100 0 0 0 0–84 100 97–100 - - 98 94–100
Pericarditis 1 1 0 0 0 0 100 2–100 100 97–100 100 2–100 100 97–100
Bacterial meningitis 4 18 3 75 17 16 25 1–81 84 76–91 6 0–27 97 91–99
Viral meningoencephalitis 3 4 2 67 3 3 33 1–91 97 92–99 25 1–81 98 93–100
Gastrointestinal infection 2 6 1 50 5 5 50 1–99 95 90–98 17 0–64 99 95–100
Malignant tumours 16 24 5 31 13 14 69 41–89 86 78–93 46 26–67 94 87–98
Cardiovascular disease 11 19 1 9 9 9 91 59–100 91 84–96 53 29–76 99 94–100
Gastrointestinal diseases 2 3 1 50 2 2 50 1–99 98 94–100 33 1–91 99 95–100
Kidney disease 1 6 1 100 6 5 0 0–97 95 89–98 0 0–46 99 95–100
Pulmonary disease 2 1 1 50 0 0 50 1–99 100 97–100 100 2–100 99 95–100
CI: Confidence interval
https://doi.org/10.1371/journal.pone.0220657.t001
Clinico-pathological discrepancies in adult death in sub-Saharan Africa
PLOS ONE | https://doi.org/10.1371/journal.pone.0220657 September 6, 2019 6 / 13
wither in relation to viral load (5/7, 71% in patients with>100,000 copies, 28/46, 61% in
patients with 15–100,000 copies, 14/20, 70% in patients with positive HIV antibodies and no
quantifiable viral copies; p = 0.7542). Information on prophylactic cotrimoxazol was available
in 55/73 HIV positive subjects. No differences were observed between patients receiving or not
prophylactic cotrimoxazol (17/29, 59% vs. 18/26 69%; p = 0.5752).
Overall, 38 patients (34%) died within 24 hours of admission, 19 (17%) between 24–48
hours and 53 (47%) more than 48 hours after admission. No data on time between admission
and death was available in two cases (2%). No statistically significant association was identified
between time from admission to death and percentage of major discrepancies (24/38, 63%
major clinical errors in patients who died within 24 hours of hospitalisation, and 40/72; 55% in
patients who died after 24 hours of hospitalisation, p = 0.4421; 34/57, 60%, major clinical
errors in patients who died within 48 hours vs. 30/53, 57%, in patients who died after 48 hours
of hospitalisation, p = 0.7463).
The most relevant associations between demographic data, clinical symptoms at admission
and biochemical and imaging results, and type of clinic-pathological discrepancies are shown
in Table 3. The table includes all statistically significant associations, as well as some relevant
demographic data. The crude model, as well as the model adjusted for HIV status is presented.
In the crude analysis, major discrepancies were most frequent in patients who presented head-
ache and had been under antiretroviral treatment. No association was identified between other
demographic data (urban or rural origin, ethnic group, smoking habit, and alcoholism), symp-
toms and signs at admission (cough, dyspnea, diarrhea, vomiting, convulsions, abdominal
pain, oliguria, dysuria, haematuria, diabetes, hypertension, treatments received before admis-
sion, weight, nutritional status, axillar temperature, dehydration, oedema, adenopathy, pallor,
jaundice, hepatomegaly, splenomegaly, petechial rash, exanthema, coma), biochemical and
imaging results (anaemia, leukocytes, urine, liver and renal analytical data) and treatments
received during hospitalisation. When adjusting for HIV status only previous antiretroviral
treatment was statistically significant.




Clinico-pathological error N % N % p-value
Class I 16 (41%) 47(64%) 0.0059 2
Class II 1 (3%) 1 (1%)
Class III 1 (3%) 0 (0%)
Class IV 0 (0%) 5 (7%)
Class V 21 (54%) 20 (27%)
Type of error
Major 17 (44%) 48 (48%) 0.0236 3
None/Minor 22 (56%) 25 (34%)
Diagnostic group
Infectious disease 21 (26%) 59 (74%) 0.0009 3
Malignant neoplasm 6 (38%) 10 (62%)
Other disease 12 (75%) 4 (25%)
2: Fisher’s exact test
3: Chi-square test
https://doi.org/10.1371/journal.pone.0220657.t002
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Discussion
To our knowledge, this is the first study conducted in sub-Saharan Africa focused on clinico-
pathological discrepancies based on complete diagnostic autopsy and including extensive sero-
logical and microbiological evaluation comprising HIV testing, as well as classical cultures and
molecular tests for bacteria, fungi, viruses, and parasites. There was a high frequency of clin-
ico-pathological discrepancies in this series of adult autopsies carried out in a tertiary-referral
hospital in Mozambique, with most being major errors. Importantly, in most patients a change
in clinical management could have significantly modified the prognosis (class I errors). The
proportion of discrepancies was higher than the rate reported in most studies [18,23–25], but
similar to the percentage observed in our previous study on maternal deaths conducted in
2009 in the same institution (Maputo Central Hospital) and also based on complete autopsy
[19]. Clinical errors were more frequent in patients with infectious diseases than in patients
with tumours or other diseases. A high rate of false negative diagnoses was found for infectious
diseases (100% for toxoplasmosis, 82% for fungal infections, 75% for bacterial sepsis and bacte-
rial meningitis, 65% for tuberculosis, and 54% for bacterial pneumonia). Interestingly, the
only clinical symptom associated with an increased frequency of major errors was headache,
probably related to the high rate of false negative diagnoses in patients with infections causing
meningoencephalitis such as toxoplasmosis and cryptococcosis. No association was found
between the time from admission to death and the percentage of major discrepancies.
Previous studies have also shown higher rates of diagnostic errors for infectious diseases
than other conditions [18,23–25]. False negative results can be due to underestimation of the
prevalence of the infectious diseases, inadequate synthesis in the diagnostic process, and the
poor sensitivity of the diagnostic tests available [26–28]. The results of our study suggest that
adequate knowledge of the prevalence of infectious diseases along with an increased level of
suspicion for most frequent infections and the implementation of accurate, low-cost,
Table 3. Relevant associations between demographic data, clinical symptoms at admission and biochemical and imaging results, and type of clinico-pathological
discrepancies. The crude model, as well as the model adjusted for HIV status is presented.











Male 24 (51%) 34 (52%) 1 - 1 -
Female 23 (49%) 31 (48%) 0.9 (0.4–2.0) 0.8967 0.9 (0.3–2.9) 0.8529
Age at death (years) 3 41.4 (13.7) 38.0 (13.0) 1.0 (0.9–1.0) 0.1972 1.0 (0.9–1.1) 0.9949
Elapsed time between admission and death (hours) 3 106.7 (125.4) 95.2 (122.3) 1.0 (1.0–1.0) 5 0.6203 1.0 (1.0–1.0) 0.7869
Fever prior to admission 2 16 (34%) 33 (51%) 2.0 (0.9–4.2) 0.0835 0.7 (0.2–2.5) 0.6155
Headache 2 6 (13%) 23 (35%) 3.5 (1.3–9.3) 0.0107 4.5 (0.7–27.8) 0.1058
Antiretroviral treatment 2 14/29 (48%) 34/41 (83%) 4.9 (1.7–14.3) 0.0034 5.6 (1.5–2.5) 0.0114
CoD group 2
Infectious diseases 24 (51%) 56 (86%) 1 0.0007 1 0.0620
Malignant neoplasms 11 (23%) 5 (8%) 0.2 (0.1–0.6) 0.2 (0.0–0.9)
Other diseases 12 (26%) 4 (6%) 0.2 (0.1–0.5) 0.2 (0.0–1.7)
HIV-status 2 25 (53%) 48 (74%) 2.4 (1.1–5.4) 2.2 (0.4–12.8)
1: Penalized-Logistic regression
2: absolute number (percentage)
3: Arithmetic Mean (Standard Deviation)
https://doi.org/10.1371/journal.pone.0220657.t003
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diagnostic tools may lead to decline of major and minor diagnostic errors [19,26,29] and may
have an impact on decreasing mortality rates.
Interestingly, the percentage of major discrepancies was higher in HIV-positive than in
HIV-negative patients. Diagnostic discrepancies rates in HIV positive patients are high in
other sub-Saharan countries [30]. In addition, the high frequency of multiple microbiological
agents in HIV-positive patients makes clinical diagnosis difficult and contributes to misdiag-
nosis or misinterpretation of complementary diagnostic methods [30]. In 85% of the HIV-pos-
itive patients, the infection had been adequately identified during life; however, only 66% of
these patients were on antiretroviral therapy. Limited access to necessary diagnostic tests in
support of HIV/AIDS and associated co-infections, such as CD4 cell counts, viral load, tuber-
culosis microscopy or molecular diagnosis, drug susceptibility testing, and cryptococcal anti-
gen testing among others, negatively contributes to the adequate clinical diagnosis, and
consequently delays initiation of drug therapy in LMIC, particularly in sub-Saharan Africa
[31,32]. These features have a critical impact on life expectancy. Laboratory infrastructure and
capacity are sub-optimal or do not exist at all in rural settings of many LMIC, which results in
a very limited diagnostic capacity. As a consequence, treatment is commonly administered in
the absence of diagnostic testing, which, in addition to the possible inadequacy of the drug,
potentially accelerates the incidence of drug-related toxicity and the onset of drug resistance.
Barriers for the expansion of necessary diagnostic testing of major infectious diseases include a
severe deficit of qualified laboratory personnel, inadequate training and insufficient educa-
tional programmes for specific diagnostic tests, inadequate standards and accreditation sys-
tems for different type of laboratories and a lack of quality control programmes. All these
limitations interfere with the quality of the tests. The cost of diagnostic equipment and con-
sumables are also challenging in most LMIC [33]. Financial constraints hamper improvements
in laboratory services, maintenance of equipment, and the procurement of laboratory supplies.
The significant reduction of diagnostic errors reported in high-income countries in the last
decades has mainly been attributed to the improvement of clinical skills and to the impact of
new diagnostic procedures [26]. Autopsy has the dual role of a method whereby diagnostic
errors can be detected and a source of knowledge to be applied to future cases, and has influ-
enced learning and provided additional data on local epidemiology of diseases. The almost
complete absence of studies based on autopsy data and focused on diagnostic errors is a severe
handicap for medical practice in sub-Saharan Africa. The increase of autopsy studies could
help to reduce mortality by providing information critical to improve diagnostic accuracy and,
therefore, clinical management.
Our study has some limitations. First, because our study was conducted in a large national
reference and university tertiary hospital, the findings observed cannot be extrapolated to
other healthcare facilities since a lower frequency of clinico-pathological discrepancies has
been reported in tertiary hospitals [18]. Thus, in primary or small health facilities the number
of diagnostic errors could be higher. On the other hand, complicated or severely ill patients are
often referred to large hospitals resulting in a high number of cases of increased diagnostic dif-
ficulty. Secondly, similarly to what has been reported in other studies [26], we found a dis-
agreement rate of 22% in class assignment, which reflects the difficulties in classifying the
discrepancy classes in some cases, which could be a limitation of the discrepancy classification.
Importantly, major clinico-pathological discrepancies may have important implications for
research. It is well known that the main source of information on the causes of death in LMIC
is verbal autopsy (method in which the cause of death is determined by analysis of interviews
to relatives or caretakers of the deceased) [34]. Obviously, verbal autopsy has been questioned
because it is subject to a relatively high degree of misclassification error [35,36]. Our data indi-
cate that medical records, and, probably also verbal autopsy diagnoses contain important a
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significant proportion of inaccuracies [37]. Interestingly, the studies based on these methodol-
ogies tend to underreport infectious diseases [38], especially in sub-Saharan Africa, vital statis-
tics, clinical registries, randomised trials, mortality reports and health policy decision, might
be based on incorrect causes of death, as autopsy is rarely the source of information.
In conclusion, major clinico-pathological discrepancies are still frequent in resource con-
strained settings including tertiary referral institutions in sub-Saharan Africa. Increasing the
level of clinical suspicion for most frequent infectious diseases and introduction of simple
diagnostic tests could significantly improve the recognition of common and life-threatening
infections, and thereby reduce the associated mortality. The high frequency of clinico-patho-
logical discrepancies questions the validity of mortality reports based on clinical data or verbal
autopsy.
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Moraleda, Fabiola Fernandes, Llorenç Quintó, Juan Carlos Hurtado, Emili Letang, Lucilia
Lovane, Dercio Jordao, Mireia Navarro, Rosa Bene, Tacilta Nhampossa, Mamudo R. Ismail,
Cesaltina Lorenzoni, Assucena Guisseve, Natalia Rakislova, Rosauro Varo, Lorena Mari-
mon, Ariadna Sanz, Anelsio Cossa, Inacio Mandomando, Maria Maixenchs, Khátia Mun-
guambe, Jordi Vila, Eusebio Macete, Pedro L. Alonso, Quique Bassat, Miguel J. Martı́nez,
Carla Carrilho, Clara Menéndez.
References
1. Shojania KG, Burton EC, McDonald KM, Goldman L. Changes in rates of autopsy-detected diagnostic
errors over time: a systematic review. JAMA 2003; 289:2849–56. https://doi.org/10.1001/jama.289.21.
2849 PMID: 12783916
2. Shojania KG, Burton EC. The vanishing nonforensic autopsy. NEnglJMed 2008; 358:873–5.
3. Hinduja A, Gupta H, Dye D. Autopsy proven causes of in hospital mortality in acute stroke. J Forensic
Leg Med 2013; 20:1014–7. https://doi.org/10.1016/j.jflm.2013.09.020 PMID: 24237810
4. Kuijpers CC, Fronczek J, van de Goot FR, Niessen HW, van Diest PJ, Jiwa M. The value of autopsies in
the era of high-tech medicine: discrepant findings persist. JClinPathol 2014; 67:512–9.
5. Wittschieber D, Klauschen F, Kimmritz A-C, von Winterfeld M, Kamphues C, Scholman H-J, et al. Who
is at risk for diagnostic discrepancies? Comparison of pre- and postmortal diagnoses in 1800 patients of
3 medical decades in East and West Berlin. PLoS One 2012; 7:e37460. https://doi.org/10.1371/journal.
pone.0037460 PMID: 22629399
6. Bansal MG, Punia RS, Sachdev A. Clinical and Needle Autopsy Correlation Evaluation in a Tertiary
Care Teaching Hospital: A Prospective Study of 50 Cases From the Emergency Department. Am J
Forensic Med Pathol 2012; 33:194–6. https://doi.org/10.1097/PAF.0b013e31823d295e PMID:
22543521
7. Liu D, Gan R, Zhang W, Wang W, Saiyin H, Zeng W, et al. Autopsy interrogation of emergency medicine
dispute cases: how often are clinical diagnoses incorrect? J Clin Pathol 2018; 71:67–71. https://doi.org/
10.1136/jclinpath-2017-204484 PMID: 28735302
8. Murken DR, Ding M, Branstetter BF, Nichols L. Autopsy as a quality control measure for radiology, and
vice versa. AJR Am J Roentgenol 2012; 199:394–401. https://doi.org/10.2214/AJR.11.8386 PMID:
22826402
Clinico-pathological discrepancies in adult death in sub-Saharan Africa
PLOS ONE | https://doi.org/10.1371/journal.pone.0220657 September 6, 2019 11 / 13
9. Schwanda-Burger S, Moch H, Muntwyler J, Salomon F. Diagnostic errors in the new millennium: a fol-
low-up autopsy study. Mod Pathol 2012; 25:777–83. https://doi.org/10.1038/modpathol.2011.199
PMID: 22362052
10. Roberts ISD, Benamore RE, Benbow EW, Lee SH, Harris JN, Jackson A, et al. Post-mortem imaging
as an alternative to autopsy in the diagnosis of adult deaths: a validation study. Lancet (London,
England) 2012; 379:136–42. https://doi.org/10.1016/S0140-6736(11)61483-9 PMID: 22112684
11. Castillo P, Ussene E, Ismail MR, Jordao D, Lovane L, Carrilho C, et al. Pathological Methods Applied to
the Investigation of Causes of Death in Developing Countries: Minimally Invasive Autopsy Approach.
PLoSOne 2015; 10:e0132057.
12. Martinez MJ, Massora S, Mandomando I, Ussene E, Jordao D. Infectious cause of death determination
using minimally invasive autopsies in developing countries. Diagn Microbiol Infect Dis 2016; 84:80–6.
https://doi.org/10.1016/j.diagmicrobio.2015.10.002 PMID: 26508103
13. Castillo P, Martinez MJ, Ussene E, Jordao D, Lovane L, Ismail MR, et al. Validity of a Minimally Invasive
Autopsy for Cause of Death Determination in Adults in Mozambique: An Observational Study. PLOS
Med 2016; 13:e1002171. https://doi.org/10.1371/journal.pmed.1002171 PMID: 27875530
14. Bassat Q, Castillo P, Martı́nez MJ, Jordao D, Lovane L, Hurtado JC, et al. Validity of a minimally inva-
sive autopsy tool for cause of death determination in pediatric deaths in Mozambique: An observational
study. PLOS Med 2017; 14:e1002317. https://doi.org/10.1371/journal.pmed.1002317 PMID: 28632739
15. Hutchins GM, Berman JJ, Moore GW, Hanzlick R. Practice guidelines for autopsy pathology: autopsy
reporting. Autopsy Committee of the College of American Pathologists. ArchPatholLab Med 1999;
123:1085–92.
16. Grinberg LT, Ferraz da Silva LF, Galtarossa Xavier AC, Nascimento Saldiva PH, Mauad T. Clinico-
pathological discrepancies in the diagnoses of solid malignancies. Pathol Res Pract 2008; 204:867–73.
https://doi.org/10.1016/j.prp.2008.07.001 PMID: 18755553
17. Goldman L, Sayson R, Robbins S, Cohn LH, Bettmann M, Weisberg M. The value of the autopsy in
three medical eras. NEnglJMed 1983; 308:1000–5.
18. Battle RM, Pathak D, Humble CG, Key CR, Vanatta PR, Hill RB, et al. Factors influencing discrepancies
between premortem and postmortem diagnoses. JAMA 1987; 258:339–44. PMID: 3599326
19. Ordi J, Ismail MR, Carrilho C, Romagosa C, Osman N, Machungo F, et al. Clinico-pathological discrep-
ancies in the diagnosis of causes of maternal death in sub-Saharan Africa: retrospective analysis. PLoS
Med 2009; 6:e1000036. https://doi.org/10.1371/journal.pmed.1000036 PMID: 19243215
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;
33:159–74. PMID: 843571
21. Firth D. Bias reduction of maximum likelihood estimates. Biometrika 1993; 80:27–38. https://doi.org/10.
1093/biomet/80.1.27
22. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002;
21:2409–19. https://doi.org/10.1002/sim.1047 PMID: 12210625
23. Sarode VR, Datta BN, Banerjee AK, Banerjee CK, Joshi K, Bhusnurmath B, et al. Autopsy findings and
clinical diagnoses: a review of 1,000 cases. HumPathol 1993; 24:194–8.
24. Marshall HS, Milikowski C. Comparison of Clinical Diagnoses and Autopsy Findings: Six-Year Retro-
spective Study. Arch Pathol Lab Med 2017; 141:1262–6. https://doi.org/10.5858/arpa.2016-0488-OA
PMID: 28657772
25. Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA. Premortem clinical diagnoses and post-
mortem autopsy findings: discrepancies in critically ill cancer patients. Crit Care 2007; 11:R48. https://
doi.org/10.1186/cc5782 PMID: 17448238
26. Sonderegger-Iseli K, Burger S, Muntwyler J, Salomon F. Diagnostic errors in three medical eras: a nec-
ropsy study. Lancet (London, England) 2000; 355:2027–31.
27. Kassirer JP, Kopelman RI. Cognitive errors in diagnosis: instantiation, classification, and conse-
quences. Am J Med 1989; 86:433–41. https://doi.org/10.1016/0002-9343(89)90342-2 PMID: 2648823
28. Voytovich AE, Rippey RM, Suffredini A. Premature conclusions in diagnostic reasoning. J Med Educ
1985; 60:302–7. PMID: 3981589
29. Zimmermann-Hösli MB, Stahel RA, Vogt P, Oelz O. Reduction of systemic fungal infections in patients
with hematological malignancies, neutropenia, and prolonged fever by early amphotericin B therapy.
Klin Wochenschr 1988; 66:1010–4. https://doi.org/10.1007/bf01733443 PMID: 3236752
30. Cox JA, Lukande RL, Nelson AM, Mayanja-Kizza H, Colebunders R, Van Marck E, et al. An Autopsy
Study Describing Causes of Death and Comparing Clinico-Pathological Findings among Hospitalized
Patients in Kampala, Uganda. PLoS One 2012; 7:e33685. https://doi.org/10.1371/journal.pone.
0033685 PMID: 22432042
Clinico-pathological discrepancies in adult death in sub-Saharan Africa
PLOS ONE | https://doi.org/10.1371/journal.pone.0220657 September 6, 2019 12 / 13
31. Cohen MC, Paley MN, Griffiths PD, Whitby EH. Less invasive autopsy: benefits and limitations of the
use of magnetic resonance imaging in the perinatal postmortem. PediatrDevPathol 2008; 11:1–9.
32. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J
Infect Dis 2007; 196 Suppl:S15–27. https://doi.org/10.1086/518656 PMID: 17624822
33. Cohen GM. Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing
countries. AIDS 2007; 21 Suppl 4:S81–87. https://doi.org/10.1097/01.aids.0000279710.47298.5c
PMID: 17620757
34. Murray CJ, Lozano R, Flaxman AD, Serina P, Phillips D, Stewart A, et al. Using verbal autopsy to mea-
sure causes of death: the comparative performance of existing methods. BMC Med 2014; 12:5. https://
doi.org/10.1186/1741-7015-12-5 PMID: 24405531
35. Anker M. The effect of misclassification error on reported cause-specific mortality fractions from verbal
autopsy. Int J Epidemiol 1997; 26:1090–6. https://doi.org/10.1093/ije/26.5.1090 PMID: 9363532
36. Chandramohan D, Setel P, Quigley M. Effect of misclassification of causes of death in verbal autopsy:
can it be adjusted? Int J Epidemiol 2001; 30:509–14. https://doi.org/10.1093/ije/30.3.509 PMID:
11416073
37. Ravakhah K. Death certificates are not reliable: revivification of the autopsy. South Med J 2006;
99:728–33. https://doi.org/10.1097/01.smj.0000224337.77074.57 PMID: 16866055
38. Fottrell E, Byass P, Ouedraogo TW, Tamini C, Gbangou A, Sombié I, et al. Revealing the burden of
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